Increased Plasma Endothelin Levels in Patients with Raynaud's Phenomenon

New England Journal of Medicine

Volumn 324, Issue 16, 1991, Pages 1139-1140

  Biondi, Maria Luisa ^a   Marasini, Bianca ^a   Bassani, Cristina ^a   Agostoni, Angelo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN;

ADULT; CONTROLLED STUDY; FEMALE; HUMAN; LETTER; MALE; PRIORITY JOURNAL; RAYNAUD PHENOMENON;

ADULT; ENDOTHELINS; FEMALE; HUMAN; MALE; MIDDLE AGE; RAYNAUD'S DISEASE;

EID: 0025876395     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199104183241618     Document Type: Letter

References (5)

1. Biondi ML, Marasini B. Abnormal platelet aggregation in patients with Raynaud's phenomenon. J Clin Pathol 1989; 42: 716–8.
2. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411–5.
3. Allen EV, Brown GE. Raynaud's disease: a critical review of minimal requisites for diagnosis. Am J Med Sci 1932; 183: 187–200.
4. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581–90.
5. Zamora MR, O'Brien RF, Rutherford RB, Weil JV. Serum endothelin-1 concentrations and cold provocation in primary Raynaud's phenomenon. Lancet 1990; 336: 1144–7.